Trial intelligence / Profile preview

Tramadol/Acetaminophen vs. Diclofenac in Ankylosing Spondylitis

NCT00766402Phase 4Terminated

Sponsor
Johnson & Johnson
Start
Sep 2008
Primary completion
Feb 2009
Modality
Irreversible Covalent Inhibitors, Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 4 trial of tramadol, acetaminophen in ankylosing spondylitis (AS), sponsored by Johnson & Johnson. Started Sep 2008; status: terminated.

02

Drugs

tramadolacetaminophen
03

Conditions

ankylosing spondylitis (AS)

Beyond the preview

Go deeper on NCT00766402.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00766402.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call